Valion Bio amends 8-K to report final vote tally on reverse stock split approval

• Valion Bio filed an amended 8-K to replace preliminary vote tallies with final results from its Aug. 14, 2026 special meeting.
• Stockholders backed a reverse stock split, granting board discretion to set a 1-for-5 to 1-for-50 ratio within 12 months.
• Final vote on the reverse split: 1,243,530 for, 697,127 against, 60,678 abstentions.
• An adjournment proposal also passed, though the meeting was not adjourned because the reverse split measure carried.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valion Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-006632), on August 20, 2026, and is solely responsible for the information contained therein.